Close Menu

NEW YORK – What articles garnered the most interest from GenomeWeb readers in the past year? Sequencing stalwart Illumina dominated the headlines with news about layoffs, insider trading, patent battles, and its beleaguered and still-pending acquisition of Pacific Biosciences. Readers were also very interested in the reported performance of 23andMe's breast and ovarian risk cancer test, and Qiagen's announcement that it was fielding acquisition offers, a potential strategy it has since shelved. Here are the top 10 for 2019:

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Washington Post reports that the CDC's SARS-CoV-2 test issues reflect earlier ones it had with Zika virus testing.

NPR writes that even with thousands of new COVID-19 papers, each should be evaluated based on its own quality.

Researchers traced a gene cluster linked to COVID-19 severity to Neanderthals, the New York Times reports.

In PNAS this week: soil bacteria-derived small molecules affect centrosomal protein, microfluidics approach for capturing circulating tumor cells, and more.